OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Past, Present and (Foreseeable) Future of Biological Anti-TNF Alpha Therapy
Gian Marco Leone, Katia Mangano, Maria Cristina Petralia, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 4, pp. 1630-1630
Open Access | Times Cited: 87

Showing 1-25 of 87 citing articles:

Cell death
Kim Newton, Andreas Strasser, Nobuhiko Kayagaki, et al.
Cell (2024) Vol. 187, Iss. 2, pp. 235-256
Open Access | Times Cited: 339

Psoriatic Arthritis: Pathogenesis and Targeted Therapies
Ana Belén Azuaga, Julio Ramírez, Juan D. Cañete
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4901-4901
Open Access | Times Cited: 76

The role of cell death in SARS-CoV-2 infection
Cui Yuan, Zhenling Ma, Jiufeng Xie, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 40

Proteome-wide Mendelian randomization identifies therapeutic targets for ankylosing spondylitis
Wenlong Zhao, Fang Peng, Chengteng Lai, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 12

Immunogenicity and Loss of Effectiveness of Biologic Therapy for Inflammatory Bowel Disease Patients Due to Anti-Drug Antibody Development
Tsvetelina Velikova, Metodija Sekulovski, Monika Peshevska-Sekulovska
Antibodies (2024) Vol. 13, Iss. 1, pp. 16-16
Open Access | Times Cited: 11

Inflammation in Fabry disease: stages, molecular pathways, and therapeutic implications
Hibba Kurdi, Lucia Lavalle, James Moon, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 11

The role of antibody glycosylation in autoimmune and alloimmune kidney diseases
Anaïs Beyze, Christian Larroque, Moglie Le Quintrec
Nature Reviews Nephrology (2024) Vol. 20, Iss. 10, pp. 672-689
Closed Access | Times Cited: 10

Navigating the Neuroimmunomodulation Frontier: Pioneering Approaches and Promising Horizons—A Comprehensive Review
Antea Kršek, Leona Ostojić, Dorotea Zivalj, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9695-9695
Open Access | Times Cited: 7

Cytokine Storm-Induced Thyroid Dysfunction in COVID-19: Insights into Pathogenesis and Therapeutic Approaches
Ali Attiq, Sheryar Afzal, Habibah A. Wahab, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 4215-4240
Open Access | Times Cited: 7

The Role of IL-23 Inhibitors in Crohn’s Disease
Jacopo Fanizza, Ferdinando D’Amico, Francesca Lusetti, et al.
Journal of Clinical Medicine (2023) Vol. 13, Iss. 1, pp. 224-224
Open Access | Times Cited: 15

Characteristic analysis of adverse reactions of five anti-TNFɑ agents: a descriptive analysis from WHO-VigiAccess
Mingming Li, Ruxu You, Yuyong Su, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 14

Reversing the Inflammatory Process—25 Years of Tumor Necrosis Factor-α Inhibitors
Katharina Muth, Jürgen Rech, Florian Losch, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 15, pp. 5039-5039
Open Access | Times Cited: 14

Nitazoxanide reduces inflammation and bone erosion in mice with collagen-induced arthritis via inhibiting the JAK2/STAT3 and NF-κB pathways in fibroblast-like synoviocytes
Changhong Li, Fengliang Wang, Yijun Han, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116195-116195
Open Access | Times Cited: 6

Design and Construction of a Synthetic Nanobody Library: Testing Its Potential with a Single Selection Round Strategy
María Angélica Contreras, Yunier Serrano-Rivero, A. González, et al.
Molecules (2023) Vol. 28, Iss. 9, pp. 3708-3708
Open Access | Times Cited: 11

Inhibition of IL-25/IL-17RA improves immune-related adverse events of checkpoint inhibitors and reveals antitumor activity
X Hu, Shoiab Bukhari, Carly Tymm, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 3, pp. e008482-e008482
Open Access | Times Cited: 4

Anti-TNFα in inflammatory bowel disease: from originators to biosimilars
Zhen Zeng, Hao Lin, Mingshan Jiang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4

Food allergens in immune systems
Woosuk Kim, Myung Suk Choi, Saerok Shim, et al.
Food Science and Biotechnology (2025) Vol. 34, Iss. 10, pp. 2079-2085
Closed Access

The combined immunization of cervical cancer therapeutic vaccine based on Listeria balanced lethal system has a significant therapeutic effect on tumor model mice
Qian Ou, Jing Tang, Yunwen Zhang, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114124-114124
Closed Access

The effects of prenatal administration of tumor necrosis factor-α on osteocalcin and RANK expression in newborn mice
Mohsen Basiri, Farhad Mortezazadeh, Seyed Noureddin Nematollahi‐Mahani, et al.
Journal of Molecular Histology (2025) Vol. 56, Iss. 2
Closed Access

Design, Synthesis, and Biological Evaluation of New Tetrahydropyrimidine Derivatives as Multitarget Anti-Inflammatory Agents
Ahmed R. Ali, Ahmed K. Al-Kubeisi, Bassma H. Elwakil, et al.
European Journal of Medicinal Chemistry Reports (2025), pp. 100259-100259
Open Access

Epigallocatechin -3- gallate mitigates diazinon neurotoxicity via suppression of pro-inflammatory genes and upregulation of antioxidant pathways
Charles Etang Onukak, Omowumi Femi‐Akinlosotu, Adedunsola Adewunmi Obasa, et al.
BMC Neuroscience (2025) Vol. 26, Iss. 1
Open Access

Genetic polymorphisms on temporomandibular disorders: Network meta-analysis
Daniel Augusto de Faria Almeida, Camila Freire Brant, Letícia da Costa Siqueira, et al.
Archives of Oral Biology (2025) Vol. 174, pp. 106235-106235
Closed Access

Toll-like Receptor Gene Polymorphisms as Predictive Biomarkers for Response to Infliximab in Japanese Patients with Crohn’s Disease
Jingjing Wei, Hiroki Kurumi, Hajime Isomoto, et al.
Diagnostics (2025) Vol. 15, Iss. 8, pp. 971-971
Open Access

Page 1 - Next Page

Scroll to top